KALA BIO, Inc. Skyrocketed
KALA BIO, Inc. (KALA:NASDAQ) soared at $1.33, a gain of 37.7%. On Mon, Dec 01, 2025, KALA:NASDAQ hit a New 2-Week High of $1.33. The stock appeared on our News Catalysts scanner on Mon, Dec 01, 2025 at 07:54 AM in the 'AGREEMENT' category. From Mon, Nov 17, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Mon, Dec 01, 2025 at $1.91 with a volume of 168M+.
About KALA BIO, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Fly-E Group, Inc. (FLYE:NASDAQ), 252.46%
- Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 198.13%
- Q32 Bio Inc. (QTTB:NASDAQ), 74.43%
- GDEV Inc. (GDEV:NASDAQ), 43.57%
- Fitell Corporation (FTEL:NASDAQ), 41.18%
- KALA BIO, Inc. (KALA:NASDAQ), 37.67%
- Beyond Meat, Inc. (BYND:NASDAQ), 36.48%
- Zhibao Technology Inc. (ZBAO:NASDAQ), 35.11%
- WEBUY GLOBAL LTD. (WBUY:NASDAQ), 34.81%
- YXT.COM Group Holding Limited (YXT:NASDAQ), 29.09%